The NMR structure of the murine DLC2 SAM domain reveals a variant fold that is similar to a four-helix bundle
© Kwan and Donaldson; licensee BioMed Central Ltd. 2007
Received: 02 January 2007
Accepted: 22 May 2007
Published: 22 May 2007
The tumor suppressor DLC2 (Deleted in Liver Cancer -2) participates in cell signaling at the mitochondrial membrane. DLC2 is characterized by a SAM (sterile alpha motif) domain, a Rho GTPase activating protein (GAP) domain, and a START lipid transfer domain.
Towards understanding the function of DLC2, we have solved the NMR solution structure of the SAM domain. The DLC2-SAM domain structure reveals an atypical four-helix composition that is distinct from the five-helix SAM domain structures that have been determined to date. From structural alignments, helix 3 of the canonical SAM domain appears to be replaced by shorter, extended secondary structure that follows a similar path. Another difference is demonstrated by helices 1 and 2 that form a helical hairpin that is situated approximately parallel to the canonical helix 5.
The DLC2-SAM domain adopts a structure that is topologically more similar to an anti-parallel four-helix bundle than a canonical SAM domain. This alternate topology may allow the DLC2-SAM domain to interact with a novel set of ligands.
Many tumors demonstrate a characteristic, non-random deletion of chromosomal material, termed loss of heterozygosity (LOH). From molecular genetics studies, Deleted in liver cancer-1 (DLC1)  and a closely related gene, DLC2  were discovered at two distinct chromosomal loci known to be sensitive to LOH. The DLC1 and DLC2 proteins share 51 % amino acid identity. Several studies suggest that DLC1 and DLC2 are tumor suppressors involved in the progression of a wide range of cancers . For example, reintroduction of DLC1 suppresses proliferation of breast carcinoma  and hepatoma cells  and prevents the formation of tumors in nude mice. Expression of DLC2 prevents the formation of Ras induced foci in NIH3T3 cells . From examinations of several cancers, point mutations leading to the inactivation of DLC1 are rare. Rather, DLC1 appears to be downregulated by promoter methylation .
At 1113 residues, murine DLC2 is a large protein with relatively few identifiable domains. Based upon sequence homology and a recent deletion study , the amino terminus of DLC2 contains a Sterile Alpha Motif (SAM) domain . Following an expanse of unknown function, a GTPase activating domain (GAP) capable of inactivating Rho and Cdc42 is situated near the carboxyl terminus . A steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domain completes the protein and localizes DLC2 to mitochondria that are proximal to lipid droplets . All of these domains are likely to be regulated by an array of intra- and intermolecular protein partnerships. The SAM domain, which has a rich history as a protein-ligand binding motif , represents an excellent focal point for exploring DLC2 partnerships in detail.
Towards determining its functional role, we present the structure of the murine DLC2-SAM domain solved using nuclear magnetic resonance (NMR) methods. Consistent with secondary structure predictions, the DLC2-SAM domain lacks what would be the third helix of a canonical, five helix SAM domain. Furthermore, the first two helices occur in a unique orientation. Combined, these differences result in a structure that resembles an anti-parallel four-helix bundle as much as it resembles a SAM domain. Upon closer inspection of the structure, a hydrophobic cleft lined with aromatic residues may offer a binding site for a unique class of ligands.
Far UV CD spectra indicate that DLC2 (22–137), DLC2 (50–120) and DLC2 (50–137) were all folded with a majority of α-helical content as shown by two characteristic minima at 208 and 222 nm (Figure 1b). In exon 1 (aa. 1–57), the PHD secondary structure algorithm  predicts the presence of one α-helix spanning residues 22–36 immediately preceding the start of the SAM domain. Assuming an α-helix is present in exon 1, the predicted mean residue ellipticities (MRE) at 222 nm for DLC2 (50–120), DLC2 (22–137) and DLC2 (50–137), are 15100, 12700, and 13700 deg·cm2·dmol-1, respectively. Alternatively, if no α-helix is present in exon 1 of DLC2 (22–137), the predicted ellipticity decreases to 10100. Together, the three spectra presented in Figure 1a appear to underestimate the predicted MREs by ~10%, which may be due in part to a systematic error in the estimation of protein concentration. Regardless, at a qualitative level, the similarity in the absolute MREs between DLC2 (22–137) and DLC2 (50–137) suggest that an α-helix may be present in exon 1.
The shortest fragment, DLC2 (50–120) demonstrated a thermal denaturation midpoint (or melting point) that was approximately 5°C lower than DLC2 (22–137) and DLC2 (50–137) suggesting that residues beyond Arg120 contribute stabilizing contacts. Since DLC2 (22–137) and DLC2 (50–137) demonstrated similar melting points, it suggests that the N-terminal sequence immediately flanking the DLC2-SAM domain does not provide any additional stabilizing contacts.
Following the CD study, the three DLC2-SAM protein fragments were 15N-labeled for NMR analysis. Amide HSQC spectra of DLC2 (22–137) and DLC2 (50–137) were nearly identical both in terms of the number of amide resonances and their absolute chemical shifts (data not presented). The similarity between the two spectra suggests that residues 22–49 occur in intermediate exchange and therefore do not interact with the SAM domain. A comparison of the DLC2 (50–137) and DLC2 (50–120) HSQC spectra revealed several sharp resonances that were not present in DLC2 (50–120). In the absence of chemical shift assignments, these sharp resonances would be attributed to a disordered stretch extending from the C-terminal end of the SAM domain. Taken together, these CD spectra and NMR HSQC spectra indicate that the minimal protein fragment of DLC2 encompassing the SAM domain is consistent with the boundaries (aa. 58–129) predicted by exons and sequence similarity.
While the spectra of DLC2 (50–120) were qualitatively easier to interpret due to the absence of sharp resonances and the reduced 1H chemical shift degeneracy, this protein fragment could only be concentrated to 0.3 mM thereby precluding any structural studies. Furthermore, preparations of DLC2 (50–120) precipitated when mixed with Pf1 bacteriophage for NMR orientational studies. In contrast, preparations of DLC2 (50–137) were stable up to a concentration of 1 mM and could be mixed with Pf1 bacteriophage. Based upon greater solubility and thermal stability, DLC2 (50–137) was selected for structural studies.
Statistics for the ensemble of structures of the murine DLC2 SAM domain a
Sequential (|i-j| = 1)
Medium range (2 ≤ |i-j| ≤ 4
Long range (4 < |i-j|)
Hydrogen bond pairs (HN-O, N-O)
Residual Dipolar Couplings
> 0.5 Å
0.0 ± 0.0
> 0.3 Å
18.0 ± 3.2
Dihedral angle restraints b
φ/ψ angles for each amino acid
Deviations from standard geometry (XPLOR-NIH)
0.0125 ± 0.0004
1.4838 ± 0.0399
1.9898 ± 0.2513
Pairwise RMSD (Secondary structure c )
0.64 ± 0.11 Å
All heavy atoms
1.47 ± 0.16 Å
Ramachandran Statistics d
Most favored regions
Additional allowed regions
Generously allowed regions
Previously, we solved the NMR structure of the S. cerevisiae Ste50-SAM domain . Based upon sequence similarity, number of helices and the position of the helices, the Ste50-SAM domain demonstrates a typical fold and therefore, is a good basis for comparison with the DLC2-SAM domain structure. As well, Ste50, like other SAM domains including Drosophila Ph, Scm, Yan and Mae  presents two complementary surfaces for high-affinity SAM-SAM interactions. Overall, the SAM domains of DLC2 and Ste50 [PDB: 1Z1V] superimposed with a Cα root-mean-square deviation (RMSD) of 3.1 Å over 42 residues (Z-score = 2.5). As illustrated in Figure 2b, the DLC2-SAM domain differs from a canonical, five-helix SAM domain fold of Ste50 in two distinct ways.
The relative orientation of a hairpin defined by helices H1 and H2 represents a second major distinction between the Ste50 and DLC2-SAM domains. In a typical SAM domain, the hairpin is approximately perpendicular to helix H5. In contrast, the helical hairpin of DLC2-SAM occurs in an anti-parallel orientation to helix H5. Key unambiguous experimental NOE observations defining this orientation are derived from Tyr69 in helix H2 (Hδ = 6.40 ppm, Hε = 6.65 ppm) and Leu103 in helix H5 (Hδ1 = -0.18 ppm, Hδ2 = 0.30 ppm). Both of these residues are distinguished by their upfield chemical shifts. Interestingly, the side chain of Trp66, a bulky residue conserved throughout all SAM domains in helix H1, is similarly positioned near helix H5 in both DLC2-SAM and Ste50-SAM domain structures. Thus, Trp66 may be considered a pivot point through which the helical hairpin has been rotated.
Interhelical angles of selected four-helix bundles and SAM domains a
Helix Pair c
A dynamics study was performed to supplement the DLC2-SAM domain structure determination. Amide 15N T1 and T2 relaxation times and heteronuclear NOE enhancements were measured at 23°C. In general terms, T1 relaxation rates and heteronuclear NOE enhancements tend to be sensitive to fast motions at the ns timescale. On the other hand, T2 relaxation rates are sensitive to slower processes. A global molecular tumbling time, or correlation time, can be determined from the ensemble of T1 and T2 rates. As larger molecules tumble slower, the correlation time provides insight into the oligomeric state of a given protein. From gel filtration studies performed at μM concentrations, the DLC2-SAM domain elutes as a single peak with a retention time that is consistent with a monomeric protein (data not presented).
At 1.3 mM, the concentration used for the NMR structural study, the average T1/T2 ratio was 10.96 ± 1.35 reflecting a correlation time (tc) of 10.3 ns. When the sample was diluted in half to 0.65 mM and then in half again to 0.33 mM, the T1/T2 ratios dropped slightly to 9.88 ± 1.22 and 9.85 ± 1.26 with respective correlation times of 9.44 ns and 9.46 ns. At a similar protein concentration and ionic strength, the S. cerevisiae Ste11 kinase SAM domain demonstrates a comparable correlation time of 9.3 ns . The observed reduction in correlation times suggests that the DLC2-SAM domain has a slight concentration dependent propensity to self-associate. Supporting this conclusion, DLC2-SAM domain preparations for NMR spectroscopy were observed to polymerize into a gel over a period of months, even at 4°C and in the presence of reducing agents to prevent oxidization of the three solvent exposed cysteines. Weak self-association has been documented previously for the Ste11  and human Ephrin kinase B2 SAM domains . However, unlike these two SAM domains, no concentration dependent chemical shift changes were observed suggesting that DLC2-SAM self-association is much weaker. At low concentrations (0.3 mM), the minimal DLC2-SAM protein fragment (50–120) had sufficient solubility for a relaxation study to be performed. From a similar T1 and T2 relaxation rate analysis, the loss of 17 C-terminal residues reduced the global correlation time from 9.46 to 7.83 ns.
Convergence and divergence of signals through Ras and Rho represent some of the most studied cases in the literature . By targeting Rho, Cdc42, and possibly other GTPases, the GAP activity of DLC2 exerts a repressive effect on cell proliferation and regulates the formation of actin stress fibers and focal adhesions . Combined, these abilities have earned DLC2 the designation as a tumor suppressor. Since RhoGAP signaling proteins such as DLC2 outnumber their potential GTPase targets by over a factor of 2:1, a considerable level of crosstalk is expected . While the GAP domain of DLC2 possesses all of the necessary determinants to interact with Rho, additional sequences are likely necessary to couple DLC2 to multiprotein signaling complexes. A yeast two-hybrid study using full length DLC2 as bait identified a number of interacting proteins that shared no singular functional class . The SAM domain of DLC2, owing to its established role in protein-protein interactions, is an obvious choice for beginning a refined study of DLC2 partners.
As previously demonstrated by the homo-oligomeric forms of the Ste11 , Tel , Ephrin A4  and Ephrin B2  structures, SAM domains are capable of displaying a variety of protein interaction surfaces despite their relatively small size. Over the last five years, the repertoire of SAM domain/ligand interactions has been extended to include nucleic acids and lipids. Reinforcing the versatility of the fold, the surfaces employed by this emerging class of SAM domains are distinct from their protein-binding counterparts. For example, the Vts1 and Smaug SAM domains bind specific pentaloop hairpin RNAs at a shallow site that draws upon contributions from helices H1 and H5 . The p73 SAM domain has been demonstrated to partially embed in both anionic and zwitterionic lipid membranes accompanied by predicted conformational changes in helices H1 and H3 .
Four isoforms of human DLC2 (DLC2α-δ) have been reported . DLC2α and DLC2β exhibit only minor amino terminal deletions before the SAM domain. DLC2γ lacks the SAM domain while DLC2δ is a very short deletion (1–135) only possessing a SAM domain. At present, no information is available regarding cells overexpressing the DLCδ isoform. Does the overexpression of the SAM domain bind and suppress other signaling protein partners leading to a phenotypic change? Of note, only the DLC2γ isoform could be stably expressed in HepG2 hepatoma cells suggesting the SAM domain may increase the suppressive strength of signals through Rho.
In yeast, the Ste50-SAM domain acts as a high-affinity beacon that recruits the Ste11 MAP kinase to Cdc42 GTPase-associated complexes involved in filamentous growth and the response to high osmolarity environment . With its unique four-helix bundle fold and hydrophobic surface lined with aromatic residues, the DLC2-SAM domain may serve an analogous role by coupling receiver and effector proteins to inactive Rho- and Cdc42-associated complexes.
The DLC2-SAM domain structure appears to be a hybrid of a SAM domain and an anti-parallel four-helix bundle. As a result, DLC2 may interact with a new class of biomolecular ligands, including peptides and lipids.
Note Added in Proof
During revision of this manuscript, a structural study of the human DLC2-SAM domain was published . Since coordinates of human DLC2 [PDB: 2H80] were unavailable, we could not perform a detailed comparison with the murine DLC2-SAM domain fragment presented in this study. In general terms, the number and position of the secondary structures of the human DLC2-SAM domain, as well as its topology, are in agreement with our murine DLC2-SAM data. Furthermore, we obtained a comparable correlation time indicating that both the human and murine DLC2-SAM domains occur in a predominantly monomeric form over a wide range of concentrations.
Cloning and Expression
Gene fragments encoding residues 1–137, 22–137, 50–120, and 50–137 of murine DLC2 were PCR amplified from the ATCC (Rockville, MD) cDNA clone 8437456 (GenBank: BC027830) and inserted into pET15b (Novagen). The expressed proteins have a 19 residue hexahistidine affinity tag and thrombin protease site appended to the amino terminus. Milligram quantities of isotopically labeled DLC2 SAM domain [50–137] were produced from a 1 L fermentation of E. coli BL21:DE3 in M9 minimal media supplemented with 15N-ammonium chloride and 13C-glucose as the sole nitrogen and carbon sources. The remaining fragments were isotopically labeled with 15N for screening purposes. All affinity tagged protein were purified using chelating nickel affinity chromatography and gel filtration chromatography (Sephadex S-100 16/60 column; GE Biosciences). Buffer conditions for all DLC SAM protein fragments were standardized to 20 mM sodium phosphate, pH 7.8, 175 mM NaCl, 0.05 % sodium azide, 5 mM dithiothreitol-d10.
NMR spectroscopy and structure determination
Protein preparations of DLC SAM (50–137) for NMR structure determination were concentrated to 0.8 mM in the aforementioned standard buffer supplemented with 10% D2O. All NMR experiments were performed on a 600 MHz Varian NMRS instrument equipped with a room temperature, single axis, pulsed field gradient, triple axis probe. Standard Varian BioPack pulse sequences were employed. Backbone assignments were determined from 2D 15N-HSQC, 2D 13C-HSQC, 3D HNCACB, 3D CBCA(CO)NH, and 3D HNCO spectra. Side chain assignments were achieved from 3D H(CCO)NH, 3D C(CO)NH, and 3D HCCH-TOCSY spectra. Aromatic rings were assigned from 2D (HB)CB(CGCD)HD, 2D (HB)CB(CGCDCE)HE, and 3D HCCH-TOCSY spectra. NOE distance restraints were obtained from 3D 15N HSQC-NOESY (100 ms mixing time), 3D 13C HSQC-NOESY (100 ms) and 3D aromatic 13C HSQC-NOESY (80 ms) spectra. Amide residual dipolar couplings were obtained as JNH differences from 2D IPAP-HSQC spectra  of the original (isotropic) sample and an aligned sample containing 10 mg/mL Pf1 bacteriophage (Profos). Data were processed and interpreted using nmrPipe  and NMRView software . No stereospecific assignments were made. NOE distance restraints were calibrated from 2.4–5.5 Å using CYANA 2.1 . Hydrogen bond restraints (O-HN, 1.8–2.1 Å; O-N, 2.7–3.0 Å) were determined by assessing the initial ensemble for backbone O-HN distances < 2.4 Å and a bond angles < 25°. Backbone dihedral angles (φ/ψ) were predicted from chemical shift information using the PREDITOR method . Initial ensembles of structures were calculated with CYANA 2.1 and further refined in explicit solvent  with XPLOR-NIH 2.17.0 .
15N T1 relaxation spectra were acquired with delays of 10, 30, 50, 110, 210, 310 and 510 ms. 15N T2 relaxation spectra were acquired with delays of 10, 30, 50, 70, 90 and 110 ms. Amide heteronuclear NOE spectra were acquired with and without saturation and a total interscan delay of 5 s. Resonances were integrated and normalized with the nLinLS module of the NMRDraw software suite. Amide T1 and T2 relaxation times were calculated from least squares fitting to a monoexponential function. Heteronuclear NOE enhancements were calculated as a ratio between resonance intensities of the two spectra. A molecular rotational correlation time was calculated using a Mathematica notebook written by Dr. Pascal Mercier (Chenomx; Edmonton, AB) employing a subset of the relaxation data whose T1/T2 ratios were all within one standard deviation and whose heteronuclear NOE enhancements were > 0.65.
Circular Dichroism Spectropolarimetry
Far UV spectra of DLC2 SAM domain fragments at a concentration of 50 μM in the standard buffer were acquired with a Jasco J-810 instrument. A rectangular cell with a 0.1 cm path length was used for all measurements. Spectra were recorded from 260 – 200 nm with a scan rate of 100 nm/min and a 1.0 nm bandwidth. A midpoint denaturation temperature (Tm) was determined by heating samples from 20–80°C at 2°C/min and monitoring ellipticity at 220 nm, a wavelength that is diagnostic for α-helical content. Mean residue ellipticity at 222 nm for various DLC2-SAM protein fragments were predicted according to a previously described method .
Ramachandran analysis of the ensemble was performed using PROCHECK-NMR . Ensemble RMSDs were calculated with MOLMOL . The EBI SSM server  was used to identify structurally similar proteins in the PDB and to perform 3D pairwise comparisons. Interhelical angles were calculated with INTERHLX . Molecular graphics were produced with MOLMOL and PyMOL http://pymol.sourceforge.net.
Coordinates and restraint lists were deposited in the Protein Data Bank under accession code 2JMT. Chemical shifts were deposited in the BioMagResBank (BMRB) under accession number 15060.
Dr. David Burk (McGill Univ.) provided thoughtful comments throughout the preparation of this manuscript. Kelvin Chan, Hoshang Zakaria and Dr. Ramanan Thirumoorthy provided technical assistance with sample preparation and NMR spectroscopy. We thank Dr. K. Andrew White for the use of the CD spectrometer. LWD received funding from a Canadian Institutes of Health Research (CIHR) Operating Grant for this project. LWD is a CIHR New Investigator.
- Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC: Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998, 58(10):2196–2199.PubMedGoogle Scholar
- Ching YP, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO: Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. The Journal of biological chemistry 2003, 278(12):10824–10830. 10.1074/jbc.M208310200View ArticlePubMedGoogle Scholar
- Ullmannova V, Popescu NC: Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. International journal of oncology 2006, 29(5):1127–1132.PubMedGoogle Scholar
- Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC, Urquidi V: The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 2005, 65(14):6042–6053. 10.1158/0008-5472.CAN-04-3043PubMed CentralView ArticlePubMedGoogle Scholar
- Ng IO, Liang ZD, Cao L, Lee TK: DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res 2000, 60(23):6581–6584.PubMedGoogle Scholar
- Zhang Q, Ying J, Zhang K, Li H, Ng KM, Zhao Y, He Q, Yang X, Xin D, Liao SK, Tao Q, Jin J: Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. Cancer Lett 2007, 249(2):220–226. 10.1016/j.canlet.2006.08.019View ArticlePubMedGoogle Scholar
- Ponting CP: SAM: a novel motif in yeast sterile and Drosophila polyhomeotic proteins. Prot Sci 1995, 4(9):1928–1930.View ArticleGoogle Scholar
- Ng DC, Chan SF, Kok KH, Yam JW, Ching YP, Ng IO, Jin DY: Mitochondrial targeting of growth suppressor protein DLC2 through the START domain. FEBS Lett 2006, 580(1):191–198. 10.1016/j.febslet.2005.11.073View ArticlePubMedGoogle Scholar
- Kim CA, Bowie JU: SAM domains: uniform structure, diversity of function. Trends Biochem Sci 2003, 28(12):625–628. 10.1016/j.tibs.2003.11.001View ArticlePubMedGoogle Scholar
- Rost B, Yachdav G, Liu J: The PredictProtein server. Nucl Acids Res 2004, 32(Web Server issue):W321–6. 10.1093/nar/gkh377PubMed CentralView ArticlePubMedGoogle Scholar
- Kwan JJ, Warner N, Maini J, Chan Tung KW, Zakaria H, Pawson T, Donaldson LW: Saccharomyces cerevisiae Ste50 binds the MAPKKK Ste11 through a head-to-tail SAM domain interaction. Journal of molecular biology 2006, 356(1):142–154. 10.1016/j.jmb.2005.11.012View ArticlePubMedGoogle Scholar
- Kwan JJ, Warner N, Pawson T, Donaldson LW: The solution structure of the S.cerevisiae Ste11 MAPKKK SAM domain and its partnership with Ste50. Journal of molecular biology 2004, 342(2):681–693. 10.1016/j.jmb.2004.06.064View ArticlePubMedGoogle Scholar
- Kim CA, Sawaya MR, Cascio D, Kim W, Bowie JU: Structural organization of a Sex-comb-on-midleg/polyhomeotic copolymer. J Biol Chem 2005, 280(30):27769–27775. 10.1074/jbc.M503055200View ArticlePubMedGoogle Scholar
- Krissinel E, Henrick K: Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 2004, 60: 2256–2268. 10.1107/S0907444904026460View ArticlePubMedGoogle Scholar
- Hecht MH, Richardson JS, Richardson DC, Ogden RC: De novo design, expression, and characterization of Felix: a four-helix bundle protein of native-like sequence. Science 1990, 249(4971):884–891. 10.1126/science.2392678View ArticlePubMedGoogle Scholar
- Wei Y, Kim S, Fela D, Baum J, Hecht MH: Solution structure of a de novo protein from a designed combinatorial library. Proc Natl Acad Sci U S A 2003, 100(23):13270–13273. 10.1073/pnas.1835644100PubMed CentralView ArticlePubMedGoogle Scholar
- Kwan JJ, Warner N, Pawson T, Donaldson LW: The solution structure of the S. cerevisiae Ste11 MAPKKK SAM domain and its partnership with Ste50. J Mol Biol 2004, 342(2):681–693. 10.1016/j.jmb.2004.06.064View ArticlePubMedGoogle Scholar
- Smalla M, Schmieder P, Kelly M, Ter Laak A, Krause G, Ball L, Wahl M, Bork P, Oschkinat H: Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. Prot Sci 1999, 8(10):1954–1961.View ArticleGoogle Scholar
- Johnson PE, Donaldson LW: RNA recognition by the Vts1p SAM domain. Nat Struct Mol Biol 2006, 13(2):177–178. 10.1038/nsmb1039View ArticlePubMedGoogle Scholar
- Bar-Sagi D, Hall A: Ras and Rho GTPases: A family reunion. Cell 2000, 103: 227–238. 10.1016/S0092-8674(00)00115-XView ArticlePubMedGoogle Scholar
- Leung TH, Ching YP, Yam JW, Wong CM, Yau TO, Jin DY, Ng IO: Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. Proc Natl Acad Sci U S A 2005, 102(42):15207–15212. 10.1073/pnas.0504501102PubMed CentralView ArticlePubMedGoogle Scholar
- Peck J, Douglas G, Wu CH, Burbelo PD: Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett 2002, 528: 27–34. 10.1016/S0014-5793(02)03331-8View ArticlePubMedGoogle Scholar
- Popescu NC, Durkin ME: Rho GTPase activating protein cDNA on chromosome 13q12 is the deleted in liver cancer (DLC2) gene. Biochem Biophys Res Commun 2004, 315(4):781. 10.1016/j.bbrc.2004.02.010View ArticlePubMedGoogle Scholar
- Bhattacharjya S, Xu P, Chakrapani M, Johnston L, Ni F: Polymerization of the SAM domain of MAPKKK Ste11 from the budding yeast: implications for efficient signaling through the MAPK cascades. Protein Sci 2005, 14(3):828–835. 10.1110/ps.041122105PubMed CentralView ArticlePubMedGoogle Scholar
- Kim CA, Phillips ML, Kim W, Gingery M, Tran HH, Robinson MA, Faham S, Bowie JU: Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. The EMBO journal 2001, 20(15):4173–4182. 10.1093/emboj/20.15.4173PubMed CentralView ArticlePubMedGoogle Scholar
- Stapleton D, Balan I, Pawson T, Sicheri F: The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nature structural biology 1999, 6(1):44–49. 10.1038/4917View ArticlePubMedGoogle Scholar
- Barrera FN, Poveda JA, Gonzalez-Ros JM, Neira JL: Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes. J Biol Chem 2003, 278(47):46878–46885. 10.1074/jbc.M307846200View ArticlePubMedGoogle Scholar
- Truckses DM, Bloomkatz JE, Thorner J: The RA domain of Ste50 adaptor protein is required for delivery of Ste11 to the plasma membrane in the filamentous growth signaling pathway of the yeast Saccharomyces cerevisiae. Mol Cell Biol 2006, 26: 912–928. 10.1128/MCB.26.3.912-928.2006PubMed CentralView ArticlePubMedGoogle Scholar
- Li H, Fung KL, Jin DY, Chung SS, Ching YP, Ng IO, Sze KH, Ko BC, Sun H: Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2. Proteins 2007, 22: 22.Google Scholar
- Ottiger M, Delaglio F, Bax A: Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. J Magn Reson 1998, 131(2):373–378. 10.1006/jmre.1998.1361View ArticlePubMedGoogle Scholar
- Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A: NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 1995, 6(3):277–293. 10.1007/BF00197809View ArticlePubMedGoogle Scholar
- Johnson BA, Blevins RA: NMRVIEW: a computer program for the visualization and analysis of NMR data. J Biomol NMR 1994, 4: 603–614. 10.1007/BF00404272View ArticlePubMedGoogle Scholar
- Guntert P: Automated NMR structure calculation with CYANA. Methods Mol Biol 2004, 278: 353–378.PubMedGoogle Scholar
- Berjanskii MV, Neal S, Wishart DS: PREDITOR: a web server for predicting protein torsion angle restraints. Nucleic Acids Res 2006, 34(Web Server issue):W63–9. 10.1093/nar/gkl341PubMed CentralView ArticlePubMedGoogle Scholar
- Linge JP, Williams RM, Spronk CA, Bonvin AM, Nilges M: Refinment of protein structures in explicit solvent. PROTEINS 2003, 50: 496–506. 10.1002/prot.10299View ArticlePubMedGoogle Scholar
- Schweiters CD, Kuzewski JJ, Tjandra N, Clore GM: The XPLOR-NIH molecular structure determination package. J Magn Res 2003, 160(1):66–74.Google Scholar
- Jiménez MA, Muñoz V, Rico M, Serrano L: Helix stop and start signals in peptides and proteins. J Mol Biol 1994, 242: 487–496.PubMedGoogle Scholar
- Laskowski R, Rullman J, MacArthur M, Kaptein R, Thornton J: AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996, 8: 477–486. 10.1007/BF00228148View ArticlePubMedGoogle Scholar
- Koradi R, Billeter M, Wuthrich K: MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996, 14(1):51–55. 10.1016/0263-7855(96)00009-4View ArticlePubMedGoogle Scholar
- Yap KL, Ames JB, Swindells MB, Ikura M: Vector geometry mapping. A method to characterize the conformation of helix-loop-helix calcium-binding proteins. Methods Mol Biol 2002, 173: 317–324.PubMedGoogle Scholar